Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Institut für Medizinische Mikrobiologie und Hygiene

klinisch-theoretische Institute / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Kim, Y. O.; Park, K. -S.; Hessel, C. et al.

High carbohydrate diet induces acute liver injury, enhanced de novo lipogenesis, inflammation and fibrosis but reversible by M2 macrophage polarization

JOURNAL OF HEPATOLOGY. Bd. 66. H. 1. 2017 S. S611-S611


Alnahas, Safa; Hagner, Stefanie; Raifer, Hartmann et al.

IL-17 and TNF-alpha Are Key Mediators Of Moraxella catarrhalis Triggered Exacerbation of Allergic Airway Inflammation

FRONTIERS IN IMMUNOLOGY. Bd. 8. 2017


Friedrich, Christin; Gasteiger, Georg

ILCs and T Cells Competing for Space: More Than a Numbers Game

IMMUNITY. Bd. 47. H. 1. 2017 S. 8-10


Qureshi, Muhammad Asif; Ashfaq-Khan, Muhammad; Aslam, Misbah et al.

Innate Lymphoid Cells Type 1 and 2 are Expanded in Early Stages of Hepatocellular Carcinoma In A Novel Murine Model Close to Human Hepatocarcinogenesis

HEPATOLOGY. Bd. 66. 2017 S. 412A-413A


Gussmann, Kathrin; Kirschnek, Susanne; von Loewenich, Friederike D.

Interferon-gamma-dependent control of Anaplasma phagocytophilum by murine neutrophil granulocytes

PARASITES & VECTORS. Bd. 10. 2017


Britanova, Liudmila; Diefenbach, Andreas

Interplay of innate lymphoid cells and the microbiota

IMMUNOLOGICAL REVIEWS. Bd. 279. H. 1. 2017 S. 36-51


Gasteiger, Georg

Is adaptive-innate lymphocyte cross-talk driving mucosal disease?

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. Bd. 114. H. 6. 2017 S. 1220-1222



Weil, Sandra; Memmer, Stefanie; Lechner, Axel et al.

Natural Killer Group 2D Ligand Depletion Reconstitutes Natural Killer Cell Immunosurveillance of Head and Neck Squamous Cell Carcinoma

FRONTIERS IN IMMUNOLOGY. Bd. 8. 2017


Rusakiewicz, Sylvie; Perier, Aurelie; Semeraro, Michaela et al.

NKp30 isoforms and NKp30 ligands are predictive biomarkers of response to imatinib mesylate in metastatic GIST patients

ONCOIMMUNOLOGY. Bd. 6. H. 1. 2017